DuPont Nutrition & Health puts new Alginate on Pharma Agenda
![DuPont Nutrition & Health puts new Alginate on Pharma Agenda](https://www.pharmaexcipients.com/wp-content/uploads/2014/08/DuPont-Nutrition-Health-puts-new-Alginate-on-Pharma-Agenda.jpg)
DuPont Nutrition & Health has added an efficient pharmaceutical excipient to the portfolio of ingredients for CPhI Worldwide 2014, in Paris this October. Alginate Pharma Grade is the first in a new series of alginate-based excipients developed to ensure the active ingredients in medicinal tablets reach their biological target intact and are released on time. In the pharma portfolio you will find both excipients as well as actives.
Production is based at the DuPont plant in Landerneau, France, where the French National Authority for Medicines and Health Products Safety has approved the dedicated production line.
“We have documented the Alginate Pharma Grade in a series of trials and expect to launch additional pharma-grade alginates for specific applications in the near future. Samples are available for functionality testing,” says Peter Janetzky, sales manager, Pharma & Industrials, DuPont Nutrition & Health.
Immune health highlights
For the dietary supplement sector, DuPont will present the complete DuPont™ Danisco range of ingredients and ready-to-market concepts.
Highlights include HOWARU Protect Kids and HOWARU Protect Adults, containing selected strains of premium probiotics shown in several clinical studies to enhance the body’s natural defenses, helping children and adults to reduce the impact of cold and flu incidents .
Source: